GILEAD 701 Pill - blue capsule/oblong, 19mm
Generic Name: emtricitabine/tenofovir disoproxil
Pill with imprint GILEAD 701 is Blue, Capsule/Oblong and has been identified as Truvada 200 mg / 300 mg. It is supplied by Gilead Sciences.
Truvada is used in the treatment of Pre-Exposure Prophylaxis of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GILEAD 701
Truvada
- Generic Name
- emtricitabine/tenofovir disoproxil
- Imprint
- GILEAD 701
- Strength
- 200 mg / 300 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
water,
FD&C Blue No. 2,
aluminum oxide,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 61958-0701 | Gilead Sciences, Inc. |
| 35356-0070 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
| 52959-0969 | H.J. Harkins Company, Inc. (repackager) |
| 54569-5588 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
| 54868-5141 (Discontinued) | Physicians Total Care Inc. (repackager) |
See also:
More about Truvada (emtricitabine / tenofovir disoproxil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (40)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiviral combinations
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.